Want to see HK:8189 full AI Analyst Report?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) Revenue
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Revenue
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H had a revenue of 293.46M in the quarter ending Jun 30, 2026, with 98.26%. This bring the company's revenue in the last twelve months to 881.37M, Increased 25.71%. In the fiscal year ending Dec 31, 2025, Tianjin TEDA Biomedical Engineering Co. Ltd. Class H had annual revenue of 509.43M with 32.15% growth.
- Revenue (ttm)
- 881.37M
- Revenue Growth
- 53.32%
- P/S Ratio
- 0.60
- Revenue/Employee
- HKD 1,866,050
- Employees
- 273
- Market Cap
- HKD 305.15M
Revenue Chart
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 509.43M | 123.95M | 32.15% |
| Dec 31, 2024 | 385.48M | -12.52M | -3.14% |
| Dec 31, 2023 | 398.00M | -5.73M | -1.42% |
| Dec 31, 2022 | 403.73M | -72.66M | -15.25% |
| Dec 31, 2021 | 476.38M | 107.03M | 28.98% |
| Dec 31, 2020 | 369.36M | 10.60M | 2.96% |
| Dec 31, 2019 | 358.75M | 6.85M | 1.95% |
| Dec 31, 2018 | 351.90M | -24.01M | -6.39% |
| Dec 31, 2017 | 375.91M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.